- Oct 292026
Ginkgo Bioworks Announces Date of Third Quarter 2026 Results Presentation
Company press release furnished with a Form 8-K filed on Oct 29, 2026.
- Oct 292026
Dexcom Reports Third Quarter 2026 Financial Results
Company press release furnished with a Form 8-K filed on Oct 29, 2026.
- Oct 282026
ClearPoint Neuro Reports Third Quarter 2026 Results
Company press release furnished with a Form 8-K filed on Oct 28, 2026.
- Oct 52026
NeuroOne Reports Preliminary Fiscal Q4 Product Revenue Growth of 38.4%; Secures Record $4.5 Million Purchase Order
Company press release furnished with a Form 8-K filed on Oct 5, 2026.
- Sep 282026
Nexalin Technology Signs Definitive Exclusive Distribution and Local Manufacturing Agreement for Brazil and South America, Marking a Major Step in Its Transition Toward Commercial Revenue Generation
Company press release furnished with a Form 8-K filed on Oct 1, 2026.
- Sep 282026
Precision Neuroscience reports $250 million of securities sold in a private offering
SEC Form D notice of an offering exempt from registration (Rule 506(b)), filed Sep 28, 2026.
- Sep 42026
Intellia Therapeutics reports entry into a material definitive agreement (Form 8-K, Item 1.01)
Current report (Form 8-K) filed with the SEC on Sep 4, 2026; the quoted text is from Item 1.01.
- Aug 212026
Nexalin Technology reports entry into a material definitive agreement (Form 8-K, Item 1.01)
Current report (Form 8-K) filed with the SEC on Aug 21, 2026; the quoted text is from Item 1.01.
- Aug 192026
Nexalin Technology reports entry into a material definitive agreement (Form 8-K, Item 1.01)
Current report (Form 8-K) filed with the SEC on Aug 20, 2026; the quoted text is from Item 1.01.
- Aug 132026
NeuroOne® Reports Fiscal Q3 2026 Financial Results, Revenues Increase 16% YoY to $2.0 Million; Gross Margins Expand to 59.9%
Company press release furnished with a Form 8-K filed on Aug 13, 2026.